Guatemalan SHB (Coffea arabica)

Guatemalan SHB (Strictly Hard Bean) is a high-altitude Coffea arabica cultivar grown above 4,500 feet in Guatemala, prized for its dense bean structure and complex flavor profile rich in chlorogenic acids and caffeine. Its primary bioactive compounds, caffeine and chlorogenic acids, interact with adenosine receptors and inhibit glucose-6-phosphatase, respectively, though no clinical trials have been conducted specifically on this cultivar.

Origin & History

Guatemalan SHB (Strictly Hard Bean) is a high-altitude cultivar variant of Coffea arabica grown above 1,350 meters in Guatemala's volcanic regions. The dense beans develop slowly in cool mountain temperatures, creating complex flavor compounds through extended maturation.

Historical & Cultural Context

No historical medical or therapeutic use documented in the provided research. Available information pertains only to Guatemala's coffee cultivation history and grading systems established for commercial export.

Health Benefits

• No clinical health benefits documented - research shows only agricultural/culinary information (Evidence: None)
• No pharmacological studies available in provided research (Evidence: None)
• No biomedical data on therapeutic applications found (Evidence: None)
• No safety or efficacy trials identified (Evidence: None)
• No clinical endpoints measured in available literature (Evidence: None)

How It Works

Caffeine in Guatemalan SHB coffee acts as a competitive antagonist at adenosine A1 and A2A receptors, reducing perceived fatigue and increasing dopamine signaling in the central nervous system. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit hepatic glucose-6-phosphatase activity, potentially modulating postprandial glucose metabolism. High-altitude cultivation conditions promote slower bean maturation, concentrating these phenolic compounds and resulting in higher antioxidant capacity compared to lower-grown arabica varieties.

Scientific Research

No clinical trials, meta-analyses, or biomedical studies were found in the provided research. The available literature focuses exclusively on agricultural grading, flavor profiles, and brewing methods without any pharmacological or health-related investigations.

Clinical Summary

No clinical trials have been conducted specifically on Guatemalan SHB as a distinct cultivar; available evidence is extrapolated from general Coffea arabica research. Broad arabica coffee studies, including meta-analyses of observational cohorts with tens of thousands of participants, associate habitual coffee consumption with reduced risk of type 2 diabetes and neurodegenerative disease, largely attributed to chlorogenic acids and caffeine. The 'SHB' designation refers to an agricultural grading standard based on altitude and bean hardness, not a pharmacologically distinct subspecies, so cultivar-specific health claims remain unsupported by direct evidence. Consumers should treat health benefits as those of high-quality arabica coffee generally, not as unique properties of this specific grade.

Nutritional Profile

Guatemalan SHB (Strictly Hard Bean) Coffea arabica refers to high-altitude grown (above 1,350m) Guatemalan coffee beans. Per 100g of roasted whole beans (approximate values): Calories: 300-330 kcal; Protein: 10-13g; Fat: 10-15g (primarily linoleic acid ~45%, palmitic acid ~30%); Carbohydrates: 35-45g (including ~25-30g insoluble fiber, ~2-3g sucrose remaining post-roast); Moisture: 1-5%. Key bioactive compounds per 100g roasted beans: Caffeine: 1.0-1.5g (Arabica typically lower than Robusta); Chlorogenic acids (CGAs): 1.5-3.5g (predominantly 5-caffeoylquinic acid; reduced from ~6-8g in green beans due to roasting degradation, with Maillard reaction products formed); Trigonelline: 0.5-1.0g (partially converted to nicotinic acid/niacin during roasting, yielding ~10-40mg niacin/100g); Diterpenes (cafestol: 200-600mg, kahweol: 100-400mg; bioavailability dependent on brewing method — unfiltered methods retain these, paper filtration removes ~95%); Melanoidins: 15-25g (formed during roasting, act as dietary fiber analogs and antioxidants). Minerals per 100g roasted beans: Potassium: 1,600-2,000mg; Magnesium: 180-250mg; Phosphorus: 150-200mg; Calcium: 100-150mg; Iron: 4-6mg (low bioavailability due to polyphenol chelation); Zinc: 0.5-1.0mg; Manganese: 1-3mg. Per standard 8oz brewed cup (~240ml, ~10g ground coffee): Caffeine: 80-120mg; CGAs: 70-200mg; Potassium: 100-150mg; Magnesium: 7-12mg; Niacin (vitamin B3): 0.5-1.5mg; trace riboflavin (B2): ~0.1mg. SHB designation indicates higher bean density from altitude, often associated with marginally higher CGA concentrations and more complex organic acid profiles (citric, malic, quinic acids) compared to lower-altitude Guatemalan beans. Antioxidant capacity (ORAC) of brewed Arabica: ~2,500-3,000 µmol TE per 240ml cup, largely attributable to CGAs and melanoidins. Bioavailability notes: CGAs are ~33% absorbed in the small intestine; the remainder reaches the colon where microbial metabolism yields dihydrocaffeic acid and other metabolites. Caffeine is nearly 100% bioavailable with peak plasma levels at 30-60 minutes post-ingestion.

Preparation & Dosage

No clinically studied dosage information available. The research contains only culinary brewing recommendations (8-10g coffee per 6oz water) without medical dosing data. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of biomedical research

Safety & Interactions

Caffeine content in Guatemalan SHB coffee carries standard caffeine-related risks including insomnia, elevated heart rate, and anxiety at doses above approximately 400 mg per day in healthy adults. Caffeine interacts with stimulant medications, certain antibiotics such as ciprofloxacin (which inhibits caffeine metabolism via CYP1A2), and anticoagulants like warfarin, potentially altering drug plasma levels. Chlorogenic acids may modestly reduce non-heme iron absorption, which is a concern for individuals with iron-deficiency anemia. Pregnant individuals are advised to limit total caffeine intake to under 200 mg per day per major obstetric guidelines, and those with hypertension, anxiety disorders, or gastroesophageal reflux should use caution.